Skip to content
28 Jan – 7 Feb 2027

Neurology Semmelweis Here

Research at Semmelweis explores clinical parameters predicting the effect of subthalamic stimulation on gait in Parkinson’s disease.

The Clinical and Research Centre for Molecular Neurology at Semmelweis conducts research on rare neurological disorders and frontotemporal dementia . 4. Neuro-technology and Surgery neurology semmelweis

Researchers have identified that imaging of the temporal pole and superior temporal gyrus shows high promise in identifying Alzheimer’s disease (a-MCI) by analyzing structural and functional MRI data. Researchers at Semmelweis engage in sleep macro- and

Disclaimer: The information above is based on academic, clinical, and research outputs up to May 2026. For clinical consultation, please reach out to the Department of Neurology at Semmelweis University. publishing in high-impact journals

Researchers at Semmelweis engage in sleep macro- and microstructure analysis in neurodegenerative diseases , including Alzheimer’s disease.

The MTA-SE Neuroepidemiological Research Group (led by Dániel Bereczki, MD) focuses on the nationwide incidence and prevalence of disorders like Parkinson's disease, frequently linking national health service data with pharmacy records.

By conducting trials, publishing in high-impact journals, and engaging in European research networks, the neurology department at Semmelweis University continues to drive progress in neuroimmunology, vascular neurology, and neuro-rehabilitation, upholding the legacy of its namesake through diligent, research-oriented care.